Guangzhou Sanheyue is mentioned in the context of investment in innovative cell therapy, alongside other investors such as Hankang Capital, VStar Capital, and Sangel Capital. However, there is limited information available to clearly define its specific role or industry focus.
Focus Areas
Notable Investments
